Search

Search Constraints

You searched for: Author/Creator Colombo, Pierre-Emmanuel

Search Results

1. 2022-RA-703-ESGO Primary and interval debulking surgery in advanced ovarian cancer: real-world clinical outcomes of patients in 1st line setting, analysis from the french national ESME-unicancer database. (20th October 2022)

2. Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models. Issue 1 (1st January 2021)

3. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse. Issue 2 (19th December 2013)

4. Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE). Issue 12 (2nd December 2022)

5. Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial. (January 2017)

6. Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse. Issue 4 (11th January 2023)

7. High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers. Issue 1 (December 2015)

8. Impact of time to radiation therapy in adjuvant settings in endometrial carcinoma: A multicentric retrospective study. (April 2020)

9. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Issue 6 (23rd March 2020)

10. Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer. (February 2014)